Literature DB >> 12829522

Effect of hyperhomocystinemia and hypertension on endothelial function in methylenetetrahydrofolate reductase-deficient mice.

Agostino Virdis1, Marc Iglarz, Mario Fritsch Neves, Farhad Amiri, Rhian M Touyz, Rima Rozen, Ernesto L Schiffrin.   

Abstract

OBJECTIVE: We evaluated the effect of hyperhomocystinemia and angiotensin (Ang) II on vascular function and structure in methylenetetrahydrofolate reductase knockout mice (Mthfr+/-). METHODS AND
RESULTS: Mthfr+/- and controls (Mthfr+/+) received Ang II (400 ng/kg per min SC) or saline (14 days). Blood pressure, similar in Mthfr+/- and Mthfr+/+, was increased by Ang II. Acetylcholine- and bradykinin-induced relaxations were impaired in mesenteric resistance arteries (pressurized myograph) in Mthfr+/- and in Ang II-infused Mthfr+/+ mice and additionally blunted in Ang II-infused Mthfr+/- mice. The inhibition by L-NAME on acetylcholine was reduced in Mthfr+/- and in Ang II-Mthfr+/+ and absent in Ang II-Mthfr+/- mice. In these groups, vitamin C improved the response to acetylcholine and restored the inhibition by L-NAME. The media to lumen ratio of small arteries, similar in Mthfr+/- and Mthfr+/+, was increased by Ang II. Vascular NADPH oxidase activity, similar in Mthfr+/- and Mthfr+/+, increased after Ang II infusion. Vascular xanthine oxidase activity was also similar in Mthfr+/- and Mthfr+/+. Superoxide production in the aorta was reduced by sepiapterin and by L-NAME, suggesting that reduced bioavailability of tetrahydrobiopterin and uncoupling of nitric oxide synthase were the origin of increased reactive oxygen species in this model.
CONCLUSIONS: Mthfr+/- mice show endothelial dysfunction of mesenteric vessels probably attributable to a reduced nitric oxide bioavailability caused by oxidative excess due to uncoupling of nitric oxide synthase without vascular structural alterations. Concurrent Ang II-induced hypertension additionally reduced nitric oxide, increased NADPH oxidase activity, and induced structural alterations. Our findings suggest additive adverse effect of Ang II-dependent hypertension and hyperhomocystinemia on endothelial function.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12829522     DOI: 10.1161/01.ATV.0000083297.47245.DA

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  20 in total

Review 1.  Essential Hypertension and Functional Microvascular Ageing.

Authors:  Rosa Maria Bruno; Stefano Masi; Marco Taddei; Stefano Taddei; Agostino Virdis
Journal:  High Blood Press Cardiovasc Prev       Date:  2018-01-09

2.  Aldosterone impairs vascular reactivity by decreasing glucose-6-phosphate dehydrogenase activity.

Authors:  Jane A Leopold; Aamir Dam; Bradley A Maron; Anne W Scribner; Ronglih Liao; Diane E Handy; Robert C Stanton; Bertram Pitt; Joseph Loscalzo
Journal:  Nat Med       Date:  2007-02-04       Impact factor: 53.440

3.  Rosuvastatin prevents angiotensin II-induced vascular changes by inhibition of NAD(P)H oxidase and COX-1.

Authors:  Rocchina Colucci; Matteo Fornai; Emiliano Duranti; Luca Antonioli; Ilaria Rugani; Fatma Aydinoglu; Chiara Ippolito; Cristina Segnani; Nunzia Bernardini; Stefano Taddei; Corrado Blandizzi; Agostino Virdis
Journal:  Br J Pharmacol       Date:  2013-06       Impact factor: 8.739

4.  Targeted insertion of two Mthfr promoters in mice reveals temporal- and tissue-specific regulation.

Authors:  Laura Pickell; Qing Wu; Xiao-Ling Wang; Daniel Leclerc; Hana Friedman; Alan C Peterson; Rima Rozen
Journal:  Mamm Genome       Date:  2011-07-19       Impact factor: 2.957

5.  Hyperhomocysteinemia impairs endothelium-derived hyperpolarizing factor-mediated vasorelaxation in transgenic cystathionine beta synthase-deficient mice.

Authors:  Zhongjian Cheng; Xiaohua Jiang; Warren D Kruger; Domenico Praticò; Sapna Gupta; Karthik Mallilankaraman; Muniswamy Madesh; Andrew I Schafer; William Durante; Xiaofeng Yang; Hong Wang
Journal:  Blood       Date:  2011-06-08       Impact factor: 22.113

6.  Synergistic vascular protective effects of combined low doses of PPARalpha and PPARgamma activators in angiotensin II-induced hypertension in rats.

Authors:  C De Ciuceis; F Amiri; M Iglarz; J S Cohn; R M Touyz; E L Schiffrin
Journal:  Br J Pharmacol       Date:  2007-03-12       Impact factor: 8.739

Review 7.  Reactive oxygen species in vascular biology: implications in hypertension.

Authors:  R M Touyz; E L Schiffrin
Journal:  Histochem Cell Biol       Date:  2004-08-26       Impact factor: 4.304

8.  Homocysteine stimulates antioxidant response element-mediated expression of glutamate-cysteine ligase in mouse macrophages.

Authors:  Florian Bea; Francesca N Hudson; Haley Neff-Laford; Collin C White; Terrance J Kavanagh; Jörg Kreuzer; Michael R Preusch; Erwin Blessing; Hugo A Katus; Michael E Rosenfeld
Journal:  Atherosclerosis       Date:  2008-07-01       Impact factor: 5.162

Review 9.  The many flavors of hyperhomocyst(e)inemia: insights from transgenic and inhibitor-based mouse models of disrupted one-carbon metabolism.

Authors:  C Lee Elmore; Rowena G Matthews
Journal:  Antioxid Redox Signal       Date:  2007-11       Impact factor: 8.401

Review 10.  Murine models of hyperhomocysteinemia and their vascular phenotypes.

Authors:  Sanjana Dayal; Steven R Lentz
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-06-12       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.